Sodium-glucose cotransporter 2 (SGLT2) inhibitors and non-small cell lung cancer survival.

Juhua LuoMichael HendryxYi Dong

Published in: British journal of cancer (2023)

Our large SEER-Medicare linked data study indicates that SGLT2 inhibitors use was associated with improved overall survival of NSCLC patients with pre-existing diabetes. Further studies are needed to confirm our findings and elucidate the possible mechanisms behind the association.

Keyphrases

small cell lung cancer
type diabetes
cardiovascular disease
free survival
electronic health record
glycemic control
healthcare
advanced non small cell lung cancer
deep learning
data analysis
weight loss